Cellosaurus logo
expasy logo

Cellosaurus COLO-679rPLX4032_10muM (CVCL_RT16)

[Text version]
Cell line name COLO-679rPLX4032_10muM
Synonyms Colo-679rPLX4032_10muM
Accession CVCL_RT16
Resource Identification Initiative To cite this cell line use: COLO-679rPLX4032_10muM (RRID:CVCL_RT16)
Comments Part of: Resistant Cancer Cell Line (RCCL) collection.
Population: Caucasian.
Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).
Derived from site: Metastatic; Soft tissue; UBERON=UBERON_0034929.
Sequence variations
  • Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
  • Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
Disease Cutaneous melanoma (NCIt: C3510)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_1130 (COLO 679)
Sex of cell Female
Age at sampling 47Y
Category Cancer cell line
Publications

PubMed=22170099; DOI=10.1038/cddis.2011.129
Michaelis M., Rothweiler F., Barth S., Cinatl J., van Rikxoort M., Loschmann N., Voges Y., Breitling R., von Deimling A., Rodel F., Weber K., Fehse B., Mack E., Stiewe T., Doerr H.-W., Speidel D., Cinatl J. Jr.
Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells.
Cell Death Dis. 2:e243.1-e243.8(2011)

Cross-references
Cell line databases/resources cancercelllines; CVCL_RT16
Encyclopedic resources Wikidata; Q54814175
Entry history
Entry creation05-Mar-2018
Last entry update05-Oct-2023
Version number10